[The COVID-19 Pandemic Changes the Scientific Publication System].
作者信息
Dal-Ré Rafael, Morell Ferrán
机构信息
Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, España.
Vall d'Hebron Institut de Recerca (VHIR), CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, España.
出版信息
Arch Bronconeumol. 2021 Jan;57:17-18. doi: 10.1016/j.arbres.2020.10.010. Epub 2020 Oct 22.
Abstract
摘要
相似文献
1
[The COVID-19 Pandemic Changes the Scientific Publication System].[新冠疫情改变科学出版系统]
Arch Bronconeumol. 2021 Jan;57:17-18. doi: 10.1016/j.arbres.2020.10.010. Epub 2020 Oct 22.
2
National Publication Productivity during the COVID-19 Pandemic-A Preliminary Exploratory Analysis of the 30 Countries Most Affected.新冠疫情期间的国家出版物产出——对受影响最严重的30个国家的初步探索性分析
Biology (Basel). 2020 Sep 5;9(9):271. doi: 10.3390/biology9090271.
3
Clinical trials during the COVID-19 pandemic: Challenges of putting scientific and ethical principles into practice.2019冠状病毒病大流行期间的临床试验：将科学和伦理原则付诸实践的挑战
Perspect Clin Res. 2020 Apr-Jun;11(2):59-63. doi: 10.4103/picr.PICR_77_20. Epub 2020 May 6.
4
[Development of the publication activity at the German university hospitals for Otorhinolaryngology, Head and Neck Surgery during the SARS-CoV-2-pandemic in 2020].[2020年SARS-CoV-2大流行期间德国大学医院耳鼻喉科、头颈外科的出版活动发展情况]
Laryngorhinootologie. 2021 May;100(5):364-371. doi: 10.1055/a-1430-7735. Epub 2021 Mar 24.
5
Physical exercise and COVID-19 pandemic in PubMed: Two months of dynamics and one year of original scientific production.《PubMed 中体育锻炼与 COVID-19 大流行：两个月的动态变化与一年的原创科研成果》
Sports Med Health Sci. 2021 Jun;3(2):80-92. doi: 10.1016/j.smhs.2021.04.004. Epub 2021 May 1.
6
COVID-19-Schutzmaßnahmen in der stationären Altenpflege - Ein Mapping Review pflegewissenschaftlicher Publikationen.COVID-19在住院老年护理中的防护措施——护理科学出版物的映射综述
Pflege. 2020 Aug;33(4):199-206. doi: 10.1024/1012-5302/a000745.
7
An accelerated shift in the use of remote systems in epilepsy due to the COVID-19 pandemic.由于 COVID-19 大流行，癫痫患者对远程系统的使用加速转移。
Epilepsy Behav. 2020 Nov;112:107376. doi: 10.1016/j.yebeh.2020.107376. Epub 2020 Aug 31.
8
An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19).关于 2019 年冠状病毒病（COVID-19）的科学出版物惊人的撤回率。
Account Res. 2021 Jan;28(1):47-53. doi: 10.1080/08989621.2020.1782203. Epub 2020 Jun 23.
9
Establishment of a system for control of cross-infection and workflow in endoscopy center during the pandemic of coronavirus disease 2019.2019年冠状病毒病大流行期间内镜中心交叉感染控制及工作流程体系的建立
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):501-506. doi: 10.11817/j.issn.1672-7347.2020.200204.
10
Perils of Precipitate Publication: Fraudulent and Substandard COVID-19 Research.仓促发表的危害：欺诈性和不合格的COVID-19研究。
J Law Med. 2020 Aug;27(4):779-789.
引用本文的文献
1
Meta-epidemiological study on the publication rate of South American countries' systematic reviews of interventions registered in PROSPERO.关于在PROSPERO登记的南美洲国家干预措施系统评价发表率的元流行病学研究。
Cochrane Evid Synth Methods. 2024 Sep 11;2(9):e70002. doi: 10.1002/cesm.70002. eCollection 2024 Sep.
本文引用的文献
1
The COVID-19 Pandemic and the JAMA Network.新冠疫情与《美国医学会杂志》网络
JAMA. 2020 Sep 22;324(12):1159-1160. doi: 10.1001/jama.2020.18298.
2
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).干预治疗 COVID-19：一项具有荟萃分析和试验序贯分析的实时系统评价（LIVING 项目）。
PLoS Med. 2020 Sep 17;17(9):e1003293. doi: 10.1371/journal.pmed.1003293. eCollection 2020 Sep.
3
Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approaches.大流行首个季度开展的非工业赞助 COVID-19 临床试验：欧洲与美国方法之间的显著差异。
Expert Rev Clin Pharmacol. 2020 Sep;13(9):1067-1072. doi: 10.1080/17512433.2020.1810562. Epub 2020 Sep 3.
4
Drug treatments for covid-19: living systematic review and network meta-analysis.Covid-19 的药物治疗：系统评价和网络荟萃分析。
BMJ. 2020 Jul 30;370:m2980. doi: 10.1136/bmj.m2980.
5
Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.《羟氯喹啉和阿奇霉素治疗新型冠状病毒肺炎：一项开放标签非随机临床试验的结果》综述 Gautret等人，2010年，DOI:10.1016/j.ijantimicag.2020.105949
Int J Antimicrob Agents. 2020 Jul;56(1):106063. doi: 10.1016/j.ijantimicag.2020.106063. Epub 2020 Jul 13.
6
An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19).关于 2019 年冠状病毒病（COVID-19）的科学出版物惊人的撤回率。
Account Res. 2021 Jan;28(1):47-53. doi: 10.1080/08989621.2020.1782203. Epub 2020 Jun 23.
7
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
8
Reasons for and time to retraction of genetics articles published between 1970 and 2018.1970 年至 2018 年间发表的遗传学文章被撤稿的原因和时间。
J Med Genet. 2019 Nov;56(11):734-740. doi: 10.1136/jmedgenet-2019-106137. Epub 2019 Jul 12.
9
Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study.比较效果研究中生存网络荟萃分析与成对荟萃分析的比较：实证研究
BMJ. 2018 Feb 28;360:k585. doi: 10.1136/bmj.k585.
Zotero 插件